PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden.\', \'Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.\', \'Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.\', \'Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.\', \'Department of Medical Cell Biology, Uppsala University, SciLifeLab, Uppsala, Sweden.\', \'Department of Neurology, Danderyd Hospital, Stockholm, Sweden.\', \'Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.\', \'Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0262169
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 35020778
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35020778>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35020778>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all